Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall
24/07/2026 20:59
Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall July 24 (Reuters) - A federal judge on Friday dismissed a lawsuit accusing Abbott Laboratories ABT.N of defrauding shareholders in connection with a 2022 recall of powdered infant formula, and lying about its commitment to quality and product safety.
U.S. District Judge Steven Seeger in Chicago said that despite filing a 217-page complaint, shareholders failed to state claims against Abbott or any individual defendants.
(Reporting by Jonathan Stempel in New York; Editing by Chris Reese)
((jon.stempel@thomsonreuters.com ; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net /))
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement